Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

GILD (Common Stock)
Exchange	NASDAQ (US Dollar)
Price	$41.53
Change (%)	1.67 (3.87%)
Volume	10,959,634
Data as of 11/20/08 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Recent News

More >>

Date	Title
11/14/08	Gilead Sciences Announces Notification of ANDA Filing for Truvada
11/05/08	Gilead Sciences to Present at Three Upcoming Investor Conferences
11/01/08	Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B

Upcoming Events

More >>

Date

Title

12/02/08
through
12/04/08

Nasdaq International Investor Conference

12/02/08 8:00 a.m.
through
12/03/08

Piper Jaffray Healthcare Conference
Location	New York, NY

12/10/08
through
12/11/08

RBC Capital Markets Healthcare Conference
Location	New York, NY

Most Viewed Links

Updated 11/20/08

1.	Stock Quote
2.	Annual Reports
3.	Fundamentals - Snapshot
4.	SEC Filings
5.	Corporate Governance - Highlights

* Data collected 11/05/08 - 11/12/08

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Gilead Sciences posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.